A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Certified trainers said the best time of day to exercise for weight loss is the time you’ll stick with Morning exercisers may ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

A study finds that significant weight loss increases the risk for individuals with cardiovascular disease. New research has ...

It seems like no matter what I do, I can’t lose weight. Most of my family members struggle with their weight too. Do our ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

New research set to be presented at the European Congress on Obesity (ECO 2025) suggests that marriage significantly ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

I agree with the House Budget Committee that our government's $36-trillion debt is a problem. But who should sacrifice to ...

GLP-1 therapy is a groundbreaking approach in the treatment of obesity and metabolic health issues. GLP-1, or glucagon-like ...